PDCD1 and nasopharyngeal carcinoma: In a relatively more chemotherapy-sensitive tumor like NPC, a formal comparison of chemotherapy and dual checkpoint inhibitors compared to chemotherapy and PD-1 inhibitors in R/M NPC would be required.